One barrier preventing further investigation of PRR therapy, however, is that the molecules often induce a fever — much like the bacteria from which they originate.

They similarly showed that mtDNA activates white blood cells through the PRR known as toll-like receptor 9 (TLR9 normally senses bacterial DNA) and its downstream kinases.